Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $1.30 0 %
High/ Low $1.30 - $1.30 0%
Chg 7 Days N/A $1.30 $1.30
Chg 30 Days N/A $1.30 $1.30
Chg 12 mos 140.74 % $0.540 $1.30
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 179.30 % Width: 120.87 %
Pred. range - 3 mos $1.30 - $1.30 0 % - 0 %
Pred. range - 12 mos $2.30 - $5.09 77.30 % - 291.61 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Buy 2023-10-31 - 48 days
Short/Long MA avg 3 mos Buy 2023-10-31 - 48 days
Short MA avg 12 mos Buy 2023-10-11 - 62 days
Long MA avg 12 mos Sell 2024-01-03 - 5 days
Short/Long MA avg 12 mos Sell 2024-01-03 - 5 days
Pivot Short Sell 2024-01-08 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba P... ZYNE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT